Top
SLC9A7 has not been detected as a mutational cancer driver

SLC9A7
Ensembl id ENSG00000065923
Mutated samples
Coding Sequence 48 (0.7%)
Protein Affecting 26 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all SLC9A7 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 17 5 1.36
Uterine corpus endometrioid carcinoma No 5 4 1.74
Breast carcinoma No 5 3 0.26
Stomach adenocarcinoma No 3 3 1.86
Lung squamous cell carcinoma No 2 2 1.15
Serous ovarian adenocarcinoma No 2 2 0.63
Hepatocarcinoma No 1 1 1.11
Bladder carcinoma No 1 1 1.02
Renal clear cell carcinoma No 1 1 0.24
Chronic lymphocytic leukemia No 3 1 0.34
Colorectal adenocarcinoma No 1 1 0.44
Head and neck squamous cell carcinoma No 2 1 0.27
Glioblastoma multiforme No 2 1 0.26
Medulloblastoma No 1 0 0.00
Diffuse B cell lymphoma No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence